Discussion
Loading...

#Tag

  • About
  • Code of conduct
  • Privacy
  • Users
  • Instances
  • About Bonfire
Anti. 🐘
@antiaall3s@chaos.social  ·  activity timestamp 2 months ago

· Two studies on potential biomarkers for #MECFS were published this month
· Stellate ganglion blocks, a procedure where an anesthetic is injected into nerves in the neck, may help reduce the severity of some symptoms of #LongCOVID and ME
· An observational study is recruiting 40 people in Boston, Massachusetts to test for defects of air and blood flow in the lungs in people with Long COVID

https://thesicktimes.org/2025/07/29/research-updates-july-29/

#ResearchUpdate #COVID19

  • Copy link
  • Flag this post
  • Block
Anti. 🐘
@antiaall3s@chaos.social  ·  activity timestamp 2 months ago

· A treatment for cats with a #COVID19-related infection may help advance #LongCOVID research
· The supplement Oxaloacetate may help reduce fatigue for LC, but it “did not reach statistical significance,” according to a new study at Bateman Horne Center
· A new prospective cohort study in JAMA Oncology of 1,572 participants with cancer found that COVID-19 had a “significant impact” on these patients, incl. hospitalization, treatment disruptions, death

https://thesicktimes.org/2025/07/22/research-updates-july-22/

#ResearchUpdate

  • Copy link
  • Flag this post
  • Block
Anti. 🐘
@antiaall3s@chaos.social  ·  activity timestamp 3 months ago

· A new study in PNAS found elevated oxidative stress was a shared characteristic in both #MECFS and #LongCOVID
· RECOVER-Treating Long COVID, the clinical trials initiative run by the Foundation for the NIAID, has announced that it will hold a second annual hybrid workshop discussing the initiative’s research
· A clinical trial in the U.K. called PHOSP-I is recruiting to test the monoclonal antibody Tocilizumab

https://thesicktimes.org/2025/07/15/research-updates-july-15/

#ResearchUpdate #COVID19

  • Copy link
  • Flag this post
  • Block
Anti. 🐘
@antiaall3s@chaos.social  ·  activity timestamp 3 months ago

· The biotech company Invivyd, which makes the #COVID19 monoclonal antibody Pemgarda, announced that it has launched the SPEAR Study Group to explore the drug for #LongCOVID and post-vaccine syndrome (PVS)
· A new study from Taiwan published in Pediatrics and Neonatology found about 14% of children developed Long COVID after being infected with #SarsCoV2
· A new observational study is investigating the relationship between COVID-19 and #Diabetes

https://thesicktimes.org/2025/07/08/research-updates-july-8/

#ResearchUpdate

  • Copy link
  • Flag this post
  • Block
Anti. 🐘
@antiaall3s@chaos.social  ·  activity timestamp 3 months ago

· Scientists found a new antiviral drug prototype that prevented Long COVID in mice and could also help treat the disease
· A recent preprint shared in medRxiv found further evidence of brain damage after COVID-19
· A new clinical trial for myalgic encephalomyelitis (ME) is recruiting in Tokyo, Japan, to test the monoclonal antibody Rituximab

https://thesicktimes.org/2025/07/01/research-updates-july-1/

#ResearchUpdate #COVID19

  • Copy link
  • Flag this post
  • Block
Log in

bonfire.cafe

A space for Bonfire maintainers and contributors to communicate

bonfire.cafe: About · Code of conduct · Privacy · Users · Instances
Bonfire social · 1.0.0-rc.3.1 no JS en
Automatic federation enabled
  • Explore
  • About
  • Members
  • Code of Conduct
Home
Login